US Map / Utah
State UT

Clinical Trials in Utah

Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 187 actively recruiting studies with Utah sites out of 187 registered in total. The busiest research areas in Utah are Multiple Myeloma, Heart Failure, Non-small Cell Lung Cancer. Leading sponsors running trials in the state include University of Utah, AstraZeneca, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (41), Phase 2 (58), Phase 3 (49), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
187
Recruiting Now
187
← Back to US Map
Top Conditions in Utah
Multiple Myeloma (4)Heart Failure (4)Non-small Cell Lung Cancer (3)Ulcerative Colitis (3)Breast Cancer (3)Stroke (3)Prostate Cancer (3)Acute Myeloid Leukemia (2)Hidradenitis Suppurativa (HS) (2)Neuroblastoma (2)Non-Small Cell Lung Cancer (2)Ovarian Cancer (2)

Frequently Asked Questions — Clinical Trials in Utah

How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 187 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 187. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Multiple Myeloma, Heart Failure, Non-small Cell Lung Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Utah

NCT06707493 Phase 2
Recruiting
Ivosidenib as Post-HSCT Maintenance for AML
Condition
IDH1 Mutation
Enrollment
75 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT05850234 Phase 1, Phase 2
Recruiting
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Condition
Relapsed/Refractory Multiple Myeloma
Enrollment
232 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT06456593 Phase 2
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active...
Condition
Moderately to Severely Active Crohn Disease
Enrollment
212 pts
Location
United States, Belgium, Czechia
Sponsor
Abivax S.A.
View Trial →
NCT02966665 Phase 1
Recruiting
: Vascular Function in Health and Disease
Condition
Chronic Obstructive Pulmonary Disease
Enrollment
420 pts
Location
United States
Sponsor
D. Walter Wray
View Trial →
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
View Trial →
NCT07440225 Phase 2, Phase 3
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-...
Condition
Macular Degeneration
Enrollment
960 pts
Location
United States, Argentina, Australia
Sponsor
EyeBiotech Ltd.
View Trial →
NCT00315380 N/A
Recruiting
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Condition
Eosinophilic Granulomatosis With Polyangiitis
Enrollment
700 pts
Location
United States, Canada, Germany
Sponsor
University of Pennsylvania
View Trial →
NCT06424288 Phase 3
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps Peop...
Condition
Heart Failure
Enrollment
6,712 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT07460440 N/A
Recruiting
SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Cla...
Condition
Lung Cancer
Enrollment
240 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT06780670 Phase 2, Phase 3
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Pr...
Condition
Prostate Cancer
Enrollment
443 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06465069 Phase 1
Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Canc...
Condition
Metastatic Solid Tumor
Enrollment
460 pts
Location
United States, Australia, China
Sponsor
Eli Lilly and Company
View Trial →
NCT06032559 Phase 3
Recruiting
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as...
Condition
Opioid Use
Enrollment
450 pts
Location
United States
Sponsor
Rutgers, The State University
View Trial →
NCT07486063 EARLY_Phase 1
Recruiting
Motorized Prostheses for Lower-limb Amputees
Condition
Lower-Limb Amputation
Enrollment
40 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT07201298 N/A
Recruiting
A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three ...
Condition
Myopia
Enrollment
120 pts
Location
United States
Sponsor
Hoopes Vision
View Trial →
NCT06743126 Phase 3
Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously T...
Condition
Melanoma, Cutaneous Malignant
Enrollment
450 pts
Location
United States, Canada, France
Sponsor
Immatics US, Inc.
View Trial →
NCT07775300 Phase 3
Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive D...
Condition
Depressive Disorder, Major
Enrollment
1,000 pts
Location
United States, Australia, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT07223593 Phase 3
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disea...
Condition
Peripheral Arterial Disease
Enrollment
1,205 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
View Trial →
NCT00736749 N/A
Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Gro...
Condition
Hematopoietic Cell Transplantation Recipient
Enrollment
25,000 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT06327685 Phase 1
Recruiting
Avapritinib With Decitabine in Patients With SM-AHN
Condition
Systemic Mastocytosis With an Associated Hematologic Neoplasm
Enrollment
34 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
View Trial →
NCT06810505 Phase 3
Recruiting
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease...
Condition
Chronic Migraine
Enrollment
420 pts
Location
United States, Canada, Denmark
Sponsor
AbbVie
View Trial →
NCT06526988 N/A
Recruiting
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to I...
Condition
Heart Failure With Reduced Ejection Fraction
Enrollment
2,200 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07293351 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or...
Condition
Advanced Renal Cell Carcinoma (RCC)
Enrollment
474 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT03072927 N/A
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Condition
Lumbar Spinal Stenosis
Enrollment
8,000 pts
Location
United States
Sponsor
Stryker Instruments
View Trial →
NCT07226986 Phase 1, Phase 2
Recruiting
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetrax...
Condition
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Enrollment
123 pts
Location
United States, Australia, France
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07837973 Phase 2
Recruiting
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Condition
Overweight , Obesity
Enrollment
220 pts
Location
United States
Sponsor
Alveus Therapeutics, Inc.
View Trial →
Page 6 of 8 — 187 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology